# A Trial to Compare the Pharmacokinetics of Two Presentations of Navenibart in Healthy Participants

> **NCT07635095** · PHASE1 · RECRUITING · sponsor: **Astria Therapeutics, Inc.** · enrollment: 180 (estimated)

## Conditions studied

- Healthy Adult Participants

## Interventions

- **COMBINATION_PRODUCT:** Autoinjector
- **DRUG:** Vial and syringe

## Key facts

- **NCT ID:** NCT07635095
- **Lead sponsor:** Astria Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-21
- **Primary completion:** 2026-09
- **Final completion:** 2026-12
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07635095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07635095, "A Trial to Compare the Pharmacokinetics of Two Presentations of Navenibart in Healthy Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07635095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*